1,105,500.00
0.00 BRL
2.98 B BRL
18.46 B BRL
About Incyte Corporation
Sector
CEO
Herve Hoppenot
Headquarters
Wilmington
Website
Founded
1991
ISIN
BRI1NCBDR004
FIGI
BBG00RD6YKW5
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where I1NC34 is featured.
